Matthew Doctor Regis Corp (RGS) insider trading activity

Matthew Doctor is President and CEO of REGIS CORP. Currently has a direct ownership of 19,584 shares of RGS, which is worth approximately $512,121. The most recent transaction as insider was on Nov 22, 2024, when has been sold 16,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.6K

74.46% 3M change

74.53% 12M change

Total Value Held $512,121

Matthew Doctor Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 22 2024	BUY Grant, award, or other acquisition	-	16,500 Added 45.73%	19,584 Common Stock
Nov 05 2024	SELL Payment of exercise price or tax liability	$7,922 $23.37 p/Share	339 Reduced 9.34%	3,292 Common Stock
Feb 08 2024	SELL Payment of exercise price or tax liability	$2,605 $12.35 p/Share	211 Reduced 0.27%	76,671 Common Stock
Nov 06 2023	SELL Payment of exercise price or tax liability	$1,933 $0.53 p/Share	3,648 Reduced 4.53%	76,882 Common Stock
Nov 07 2022	SELL Payment of exercise price or tax liability	$3,574 $1.26 p/Share	2,837 Reduced 3.4%	80,530 Common Stock
Feb 08 2022	SELL Payment of exercise price or tax liability	$7,166 $1.65 p/Share	4,343 Reduced 4.95%	83,367 Common Stock
Nov 05 2021	BUY Grant, award, or other acquisition	$64,849 $1.38 p/Share	46,992 Added 38.17%	76,124 Common Stock
Feb 08 2021	BUY Grant, award, or other acquisition	-	28,382 Added 49.35%	29,132 Common Stock

Matthew Doctor

President and CEO

Minneapolis, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGS shares.

Notify only if

Value

Insider Trading

Get notified when an Regis Corp insider buys or sells RGS shares.

Notify only if

Operation

Value

Type

News

Receive news related to REGIS CORP

Track Activities on RGS

Account